<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001113148</cik>
        <entityName>INFINITY PHARMACEUTICALS, INC.</entityName>
        <fileNumber>000-31141</fileNumber>
        <address>
            <street1>1100 Massachusetts Avenue, Floor 4</street1>
            <street2></street2>
            <city>Cambridge</city>
            <stateOrCountryCode>MA</stateOrCountryCode>
            <stateOrCountry>MASSACHUSETTS</stateOrCountry>
            <zipCode>02138</zipCode>
        </address>
        <telephoneNumber>1 858 455-8600</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Aravind Menon</signatureName>
        <signatureTitle>Hearings Advisor</signatureTitle>
        <signatureDate>2023-11-20</signatureDate>
    </signatureData>
</notificationOfRemoval>